NCT01223768View on ClinicalTrials.gov

Acetyl-L-Carnitine In Severe Hepatic Encephalopathy

NACompletedINTERVENTIONAL
Timeline

Start Date

July 31, 2002

Study Completion Date

December 31, 2005

Conditions
Hepatic Encephalopathy (Grade 3 of the West Haven Grading Scale)
Interventions
DRUG

Acetyl-l-Carnitine

2g per day

DRUG

placebo

twice per day

Trial Locations (1)

95126

Cannizzaro Hospital, Catania

All Listed Sponsors
lead

University of Catania

OTHER

NCT01223768 - Acetyl-L-Carnitine In Severe Hepatic Encephalopathy | Biotech Hunter | Biotech Hunter